Horizon Discovery signed a three-year agreement with the National Human Genome Research Institute and the National Cancer Institute allowing researchers access to its Genesis rAAV gene-editing technology to generate cell lines for basic and translational research. NHGRI and Horizon researchers will develop isogenic disease models of melanoma. NCI will also develop disease models for research and establish a center for excellence in gene editing.
Public-private effort set to generate X-Man cell lines for research
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan